Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Pediatric Spine Surgery
NCT05493228Phase 3Unknown
- Sponsor
- Children's Cancer Hospital Egypt 57357
- Start
- May 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in spinal cord tumor comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Rate of propofol infusion per hour, Change in MEP amplitude and latency and 2 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
spinal cord tumor
Beyond the preview
Go deeper on NCT05493228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05493228.